Illumina Inc. Stock
Illumina Inc. Stock
The price for the Illumina Inc. stock decreased slightly today. Compared to yesterday there is a change of -€2.300 (-0.610%).
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Illumina Inc..
With a target price of €400.00 there is a slightly positive potential of 7.210% for Illumina Inc. compared to the current price of €373.10.
Pros and Cons of Illumina Inc. in the next few years
Pros
?
Conscious of the environment
?
Brand
?
Market Position
Cons
?
Shareholder structure
?
Worthwhile Investment for the next years
?
Growth compared to competition
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Illumina Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Illumina Inc. | -0.610% | 5.754% | 18.822% | 22.973% | 24.450% | 50.056% | 204.422% |
| Edwards Lifesciences Corp. | 0.820% | 5.443% | 13.026% | 37.982% | 13.441% | 478.071% | - |
| Agilent Technologies Inc. | 0.170% | 5.492% | 10.227% | 55.686% | 24.856% | 108.874% | 198.063% |
| Boston Scientific | -0.870% | 1.563% | 2.572% | 11.752% | 19.843% | 26.087% | 71.096% |
Comments
Other discussions about Illumina Inc. Stock
Trading Illumina Inc.
Trading Illumina Inc.
News
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in
Illumina To Webcast Upcoming Investor Conference
Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
-
Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021